1,502 Shares in iShares Biotechnology ETF (NASDAQ:IBB) Purchased by Robertson Stephens Wealth Management LLC

Robertson Stephens Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 1,502 shares of the financial services provider’s stock, valued at approximately $204,000.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Glass Jacobson Investment Advisors llc boosted its holdings in iShares Biotechnology ETF by 150.6% in the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 122 shares during the period. Values First Advisors Inc. bought a new stake in iShares Biotechnology ETF in the 4th quarter valued at about $43,000. Tennessee Valley Asset Management Partners acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at approximately $44,000. Column Capital Advisors LLC acquired a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at approximately $49,000. Finally, Massmutual Trust Co. FSB ADV raised its position in shares of iShares Biotechnology ETF by 164.2% in the 4th quarter. Massmutual Trust Co. FSB ADV now owns 362 shares of the financial services provider’s stock valued at $49,000 after buying an additional 225 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $132.96 on Friday. The firm has a 50 day moving average of $133.61 and a 200-day moving average of $129.99. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $141.16.

iShares Biotechnology ETF Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were given a $0.126 dividend. This represents a $0.50 annualized dividend and a dividend yield of 0.38%. The ex-dividend date of this dividend was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.